Health Care [ 4/12 ] | Health Care Technology [ 60/75 ]
NASDAQ | Common Stock
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally.
It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process.
The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services.
In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform.
The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001.
Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 5, 26 | 0.40 Decreased by -33.33% | 0.50 Decreased by -19.40% |
| Oct 29, 25 | 0.51 Decreased by -8.93% | 0.36 Increased by +41.67% |
| Jul 31, 25 | 0.45 Decreased by -11.76% | 0.27 Increased by +66.67% |
| May 6, 25 | 0.26 Increased by +766.67% | 0.20 Increased by +30.00% |
| Feb 6, 25 | 0.60 Increased by +81.82% | 0.58 Increased by +3.45% |
| Oct 30, 24 | 0.56 Decreased by -9.68% | 0.42 Increased by +33.33% |
| Aug 1, 24 | 0.51 Decreased by -10.53% | 0.14 Increased by +264.29% |
| May 2, 24 | 0.03 Decreased by -92.31% | -0.09 Increased by +133.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 313.98 M Increased by +2.32% | -2.03 M Decreased by -112.79% | Decreased by -0.65% Decreased by -112.50% |
| Sep 30, 25 | 310.63 M Increased by +9.99% | 5.46 M Decreased by -36.71% | Increased by +1.76% Decreased by -42.46% |
| Jun 30, 25 | 290.56 M Increased by +4.98% | 5.64 M Increased by +50.98% | Increased by +1.94% Increased by +43.82% |
| Mar 31, 25 | 269.67 M Increased by +9.55% | -7.02 M Increased by +55.20% | Decreased by -2.60% Increased by +59.11% |
| Dec 31, 24 | 306.88 M Increased by +18.56% | 15.84 M Increased by +210.21% | Increased by +5.16% Increased by +192.96% |
| Sep 30, 24 | 282.42 M Decreased by -5.44% | 8.63 M Increased by +55.41% | Increased by +3.06% Increased by +64.35% |
| Jun 30, 24 | 276.79 M Decreased by -7.42% | 3.73 M Increased by +8.23% | Increased by +1.35% Increased by +16.90% |
| Mar 31, 24 | 246.15 M Decreased by -15.30% | -15.68 M Decreased by -4.51% | Decreased by -6.37% Decreased by -23.39% |